Pfizer Ltd Closes Trading Window for Financial Results

Pfizer Ltd has announced the closure of its trading window for dealing in the company's shares. This closure is in preparation for the declaration of unaudited financial results for the half-year ending September 30, 2026. The trading window will be shut from Wednesday, September 30, 2026, effective at the close of business, and will reopen 48 hours after the financial results are officially published. This measure is standard practice to prevent insider trading ahead of significant financial disclosures.